strong support, page-34

thanks for your post Semi R,

it is Noble Financial Sevices in the US

... they are sponsring the Biox Conference

" Noble Financial Capital Markets (Noble) sponsors the BIOX Conference as an informational service and networking opportunity for public companies and investors "

http://www.nobleresearch.com/BIOX.htm

http://www.nobleresearch.com/Agenda.htm

this bit is interesting re Nobles involvement ...

" "Why Not Us?" Many CEO’s of small biotech companies are asking themselves why they cannot convince large pharma to license their product/technology;

licensing executives in large pharma may also be asking themselves why they cannot convince their R&D-groups or Executive Committees to make substantial investments in the licensing of a product/technology from a small biotech company.

This presentation will provide an insight by Jules Müsing, a pharma executive who has negotiated and signed several multi-hundred million dollar pharmaceutical and biotechnology licensing deals during his career, in why some biotech CEO’s are more successful than others in partnering with large pharma, and why some licensing executives in large pharma are “ stars “ and others are not. "

.... now thats enough to give me a Semi ...